USPTO 2015–2025 USPTO PatentsView US Corporation

Vyaire Medical Capital LLC

USPTO PatentsView assignee record - 25 granted patents across 9 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

RSS updates for this company

The verdict

According to USPTO PatentsView, Vyaire ranks #12,310 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 9 technology areas.

#12,310
of 49,997 US assignees by volume
Top 38%
by Innovation Score (39.4/100)
19.4
avg claims per patent
-8%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12310 · US Corporation #12,310 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

  • GRANTS-SMALL 25 grants
  • UPPER-Q #12,310/49,997
  • PHOTO-FINISH Virsec Systems
  • CPC-NARROW A61M · 9 areas
  • INNOV-THIN 39.4/100
  • CLAIMS-RICH 19.4 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-FLAT -8% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Virsec Systems, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Vyaire’s 39.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Vyaire

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Vyaire's Innovation Score is 39.4/100 (top 38% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Vyaire?

Each dot is one of Vyaire’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Vyaire’s own 19.4 claims/patent is ABOVE the 13.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Vyaire vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 24.924.92525.1 051015202530 Granted patents (volume) Avg claims / patent Virsec Systems, Inc. - 25, 25Virsec SystemsVirtual Incision Corporation - 25, 18.96Virtual IncisionVolt, LLC - 25, 10.8VoltVungle, Inc. - 25, 19.2VungleWhill, Inc. - 25, 6.52WhillWatts Water Technologies - 25, 4.92Watts WaterWestinghouse Electric Sweden AB - 25, 14.56Westinghouse Elec…Wiser Systems, Inc. - 25, 13.6Wiser SystemsVyaire Medical Capital LLC - 25, 19.44Vyaire Medical Ca…
Vyaire vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Vyaire's grants concentrate

Vyaire Medical Capital LLC is a focused PatentsView assignee: 9 CPC subclasses with 96% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2017 (7 grants) versus a trough of 1 in 2022. By volume, Vyaire sits between Virsec Systems, Inc. and Wiser Systems, Inc..

Vyaire's three-year grant acceleration

Vyaire Medical Capital LLC shows 7 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Vyaire's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Vyaire holds 25 patents at rank #12,306, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Vyaire

By rank, the assignees closest to #12,306 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Vyaire's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Vyaire, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Vyaire ranks #299 of 3,490 assignees by patent count in that subclass.

Vyaire's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 38% higher than 62% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 2017201820192020202220232024 2
USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Vyaire Medical Capital LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 7 28.0%
2018 3 12.0%
2019 3 12.0%
2020 5 20.0%
2022 1 4.0%
2023 4 16.0%
2024 2 8.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Vyaire Medical Capital LLC's patent record in context - here's where to go next.

  • Vyaire Medical Capital LLC's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 96% of its portfolio - see every assignee active in that class. Explore A61M
  • Ranked #12,310 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Vyaire Medical Capital LLC against Virsec Systems, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 39.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.